Publications

ZW191

Categories
Search
Clinical, ZW191
June 19, 2025
ESMO Gynaecological Cancers Congress
Design of a First-in-Human Multicentre Open-Label Study of ZW191, a Folate Receptor α–Targeting Antibody-Drug Conjugate Utilising a Novel TOPOIi Payload, in Participants With Advanced Solid Tumours: ZWI-ZW191-101
Sommerhalder et al.
ZW191
April 8, 2024
AACR
ZW191 – a FRα-targeting antibody-drug conjugate with strong preclinical activity across multiple FRα-expressing indications
Lawn et al.
ZW191
April 17, 2023
AACR
ZW191, a novel FRα-targeting antibody drug conjugate bearing a topoisomerase I inhibitor payload
Lawn et al.
ZW191
March 15, 2023 - March 16, 2023
World ADC London
ZW191: A Potential Best-in-Class TOPO1i ADC for Treatment of FRα-Expressing Solid Tumors
Sam Lawn